| Patricia Ann Johnson, LCSW, CSAC, MAC | |
|
86-120 Farrington Hwy, A-107, Waianae, HI 96792-3000 | |
| (808) 292-8685 | |
| (808) 696-5079 |
| Full Name | Patricia Ann Johnson |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 86-120 Farrington Hwy, Waianae, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669516209 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 3185 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Ann Johnson, LCSW, CSAC, MAC 86-120 Farrington Hwy, A-107, Waianae, HI 96792-3000 Ph: (808) 292-8685 | Patricia Ann Johnson, LCSW, CSAC, MAC 86-120 Farrington Hwy, A-107, Waianae, HI 96792-3000 Ph: (808) 292-8685 |
News Archive
Today, CLC bio announced the acquisition of Molegro, a specialized software company focusing on molecular docking, including prediction and analysis of protein-ligand interactions, screening of compound databases for activities against a receptor, and determination of molecule similarity.
While families around the world delay childbearing to later in life, cancer diagnoses are affecting people ever earlier in life. When these lifestyle trends collide, we see an increasing number of young women rendered infertile by cancer or cancer treatments.
A team of scientists led by researchers from the University of California, San Diego School of Medicine and Ludwig Institute for Cancer Research have identified a novel therapeutic approach for the most frequent genetic cause of ALS, a disorder of the regions of the brain and spinal cord that control voluntary muscle movement, and frontal temporal degeneration, the second most frequent dementia.
Research presented at the 72nd Annual Scientific Meeting of the American College of Gastroenterology found that obesity, among other important risk factors, was the strongest risk factor for colorectal cancer in women.
Bayer HealthCare and Onyx Pharmaceuticals today announced the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration and an application for marketing authorization to the European Medicines Agency for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.
› Verified 5 days ago
Ellen Kielbasa, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 87-680 Hakimo Rd, Waianae, HI 96792 Phone: 808-349-7540 | |
Ms. Sonya Louise Roundtree, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 84-265 Farrington Hwy Apt 415, Waianae, HI 96792 Phone: 808-990-4053 | |
George S Moises, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 87-908 Kulauku St, Waianae, HI 96792 Phone: 808-728-7346 | |
Alisa H. Au, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 87-2116 Farrington Hwy, Waianae, HI 96792 Phone: 808-432-3500 | |
Mrs. Betty J. Ha'o, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 85-888 Farrington Hwy, Waianae, HI 96792 Phone: 808-696-9498 Fax: 808-696-9403 | |
Jodi Kiilani Aiu Johnson, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 87-401 Manuaihue St, Waianae, HI 96792 Phone: 808-465-7352 |